Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selim Cellek

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Diabetes|August 28, 2003
Two phases of nitrergic neuropathy in streptozotocin-induced diabetic ratsSelim Cellek, Neale A Foxwell, Salvador Moncada
The Journal of Sexual Medicine|April 21, 2023
Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's diseaseMarcus M Ilg, David J Ralph, Selim Cellek
Diabetes|December 24, 2004
Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic strokeSelim Cellek, Patrick N Anderson, Neale A Foxwell
Pharmacological Research|October 1, 2008
Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colonEmma M Jarvie, Selim Cellek, Gareth J Sanger
Sexual Medicine|December 19, 2025
The experience of gay Christian men attending collaborative workshops facilitated by a sexual health professional and a priestRemziye Kunelaki, Zoe Bennett, Selim Cellek, et al.
Sexual Medicine Reviews|April 10, 2019
Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie's DiseaseUros Milenkovic, Marcus M Ilg, Selim Cellek, et al.
BJU International|June 21, 2008
The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapismAsif Muneer, Selim Cellek, David J Ralph, et al.
European Journal of Pharmacology|February 7, 2024
Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scarsAlice Ruth Lapthorn, Marcus Maximillian Ilg, Peter Dziewulski, et al.
The Journal of Sexual Medicine|July 31, 2023
A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signalsSelim Cellek, Matthew Megson, Marcus M Ilg, et al.
Plos One|December 12, 2022
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's diseaseMarcus M Ilg, Alice R Lapthorn, David J Ralph, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Diabetes|August 28, 2003
Two phases of nitrergic neuropathy in streptozotocin-induced diabetic ratsSelim Cellek, Neale A Foxwell, Salvador Moncada
The Journal of Sexual Medicine|April 21, 2023
Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's diseaseMarcus M Ilg, David J Ralph, Selim Cellek
Diabetes|December 24, 2004
Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic strokeSelim Cellek, Patrick N Anderson, Neale A Foxwell
Pharmacological Research|October 1, 2008
Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colonEmma M Jarvie, Selim Cellek, Gareth J Sanger
Sexual Medicine|December 19, 2025
The experience of gay Christian men attending collaborative workshops facilitated by a sexual health professional and a priestRemziye Kunelaki, Zoe Bennett, Selim Cellek, et al.
Sexual Medicine Reviews|April 10, 2019
Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie's DiseaseUros Milenkovic, Marcus M Ilg, Selim Cellek, et al.
BJU International|June 21, 2008
The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapismAsif Muneer, Selim Cellek, David J Ralph, et al.
European Journal of Pharmacology|February 7, 2024
Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scarsAlice Ruth Lapthorn, Marcus Maximillian Ilg, Peter Dziewulski, et al.
The Journal of Sexual Medicine|July 31, 2023
A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signalsSelim Cellek, Matthew Megson, Marcus M Ilg, et al.
Plos One|December 12, 2022
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's diseaseMarcus M Ilg, Alice R Lapthorn, David J Ralph, et al.
Pageof 6